From: Ventilator-associated respiratory infection in a resource-restricted setting: impact and etiology
All VARI (n = 92) | VAP (n = 37) | VARI without VAP (n = 55) | No VARI (n = 286) | |
---|---|---|---|---|
Age | 48 (36–61.5) | 46 (37–62) | 50 (35–62) | 53 (40–65) |
M:F | 70:22 | 25:12 | 45:10 | 197:85 |
SOFA | 3 (2–6) | 5 (2–8) | 3 (1–3) | 4 (3–7) |
APACHE | 8.5 (5–14) | 11 (5–15) | 7 (5–14) | 11 (7–15) |
BMI | 21.97 (19.72–24.56) | 22.12 (21.12–24.61) | 21.97 (19.03–23.53) | 20.56 (18.69–23.48) |
Comorbidity | 26 (28.3%) | 14 (37.9%) | 12 (21.8%) | 118 (42.1%) |
Hospital previous 90 days† | 7 (7.6%) | 3 (8.1%) | 4 (7.3%) | 34 (12.1%) |
Transferred for this illness | 69 (75%) | 27 (73.0%) | 42 (76.4%) | 212 (75.18) |
Antibiotics in last 90 days | 4 (4.4%) | 3 (8.1%) | 1 (1.8%) | 21 (7.5%) |
CNS infection | 11 (12.0%) | 1 (2.7%) | 10 (18.2%) | 49 (17.4%) |
Dengue | 3 (3.3%) | 2 (5.4%) | 1 (1.8%) | 6 (2.1%) |
Sepsis/septic shock | 11 (12.0%) | 6 (16.2%) | 5 (9.1%) | 44 (15.6%) |
Tetanus | 48 (52.2%) | 14 (37.8%) | 34 (61.8%) | 84 (29.8%) |
Pneumonia | 7 (7.6%) | 7 (18.9%) | 0 (0%) | 66 (23.4%) |